April 2019


In this Issue

Embolization: Opportunities and Obstacles

Which factors will affect widespread acceptance of emerging options?



Guest Chief Medical Editors’ Page

Embolization: Opportunities and Obstacles

By Kari J. Nelson, MD; and Patrick Haage, MD, PhD, MBA


Beyond Feasibility: Embolization for Osteoarthritis

A discussion of how embolization can fit into the osteoarthritis treatment algorithm and what is needed to gain support from the medical community.

By Siddharth A. Padia, MD

PAE: Factors That Will Influence Widespread Acceptance

A look at the current position of PAE and the opportunities and challenges of establishing its role in the treatment pathway for symptomatic benign prostatic hyperplasia.

By Timothy J.C. Bryant, BMedSci, BMBS, MRCP, FRCR

PAE and Successful Partnership With Urology

Building a successful PAE program requires collaboration between urology and interventional radiology through proper patient selection, communication, and referrals.

By James Katrivesis, MD; and Edward Uchio, MD, FACS, CPI

Reimbursement Rules: Can Payment Barriers for Uterine Artery and Pelvic Congestion Embolization Be Overcome?

Why reimbursement is limited for these procedures and what can be done to change the payment landscape.

By Theresa Caridi, MD, FSIR

Factors That Will Make or Break Bariatric Embolization for the Treatment of Obesity

The importance of defining clinical efficacy and safety in larger cohorts, determining the appropriate patient population, evaluating cost-effectiveness, and integrating bariatric embolization into the obesity care pathway.

By Godwin Abiola, BA; and Clifford R. Weiss, MD, FSIR, FCIRSE

Novel Embolotherapy and Combination Therapy for Interventional Oncology

A discussion on the landscape of IO combination therapies, the future of radiogenomics, and the effect of center and operator volume on IO procedures.

With Nadine Abi-Jaoudeh, MD, FSIR, CCRP

Roundtable Discussion: Endoleak Embolization: Tailoring Techniques and Material Selection

Experts provide insights into the best strategies for treating endoleaks with embolization.

With M.W. de Haan, MD, EBIR; Fabrizio Fanelli, MD, EBIR; Robert Morgan, MBChB, MRCP, FRCR, EBIR; Parag J. Patel, MD, MS, FSIR; and Geogy Vatakencherry, MD

Roundtable Discussion: Perennial Preparedness: Vascular Trauma Embolization

A discussion on strategies for embolotherapy in trauma patients, including how to prepare the center, the level of additional training required, and the need for effective communication between specialties.

With Shawn Sarin, MD; and Otto M. van Delden, MD, PhD


Sponsored by Penumbra, Inc.

Ruby, POD, Packing Coil, and LANTERN: A Complete Embolization Platform for Both Aneurysms and Vessels

With Darren B. Schneider, MD; Alan M. Dietzek, MD, RPVI, FACS; Charles M. Eichler, MD; Justin P. McWilliams, MD; Dmitri E. Samoilov, MD; Shabana Shahanavaz, MD; and Parag J. Patel, MD


Sponsored by Penumbra, Inc.

Ruby, POD, and POD Packing Coil: Dedicated Devices for Different Applications

With Giuseppe Guzzardi, MD; Robert G. Jones, MRCP, FRCR; Radosław Pietura, MD, PhD; Martin Zeile, MD; Pedro Pardo Moreno, MD; and Mostafa El Hajjam, MD


Sponsored by Medtronic

Treatment Strategies for Femoropopliteal Chronic Total Occlusions

By Harry W. Donias, MD



An Interview With Ian M. Loftus, MD, FRCS

Prof. Loftus discusses the pros and cons of surgeon-level outcome reporting, paths for enhanced cost-effectiveness in endovascular aneurysm repair, and more on the forthcoming NICE aortic aneurysm guidelines.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.